Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH) is a healthcare company (diagnostics & research) based in the United States. The share price is $143.34, down 0.48% on the day, which values the company at $19.39B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.
Key facts
- Share price
- $143.34−0.48% today
- Market value
- $19.39B
- Funk Score
- 55/100
- 200-week average
- $59.63140% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Guardant Health, Inc. in more detail
GH trades at -505.5× next year's expected earnings, 15.2× sales. It sits 140% above its 200-week average of $59.63.
Over the last five fiscal years Guardant Health, Inc. has compounded revenue 27.9% a year. Its Funk Score is 55 out of 100 (financial strength 4.6, profitability 2.0, growth 10.0, each out of 10).
In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Share count keeps rising; Thin interest cover.
9 of the superinvestors tracked here hold GH, including Eric Bannasch (7.4% of the portfolio), Karthik Sarma (1.7% of the portfolio), Cathie Wood (0.6% of the portfolio).
Superinvestors holding GH
9 of the investors tracked here report a position in their latest 13F filing.
- Eric Bannasch Cadian Capital Management7.43% of portfolio · $89.1M · trimmed · Q3 2026
- Karthik Sarma SRS Investment Management1.74% of portfolio · $184.9M · new · Q3 2026
- Cathie Wood ARK Invest0.62% of portfolio · $108.3M · added · Q3 2026
- Temasek Temasek Holdings0.52% of portfolio · $188.7M · added · Q3 2026
- John Overdeck and David Siegel (founders) Two Sigma Investments0.40% of portfolio · $546.4M · trimmed · Q3 2026
- Baillie Gifford team Baillie Gifford & Co0.29% of portfolio · $306.3M · trimmed · Q3 2026
- Andrew Spokes Farallon Capital Management0.26% of portfolio · $49.9M · trimmed · Q3 2026
- Steve Cohen Point72 Asset Management0.21% of portfolio · $138.1M · added · Q2 2026
- Israel Englander Millennium Management0.16% of portfolio · $243.4M · added · Q2 2026
Health Care companies of similar size
- STERISSTE
- InsmedINSM
- United TherapeuticsUTHR
- IncyteINCY
- ViatrisVTRS
- Tenet HealthcareTHC
- BioNTechBNTX
- Alnylam PharmaceuticalsALNY
- Zimmer Biomet HoldingsZBH
- Medpace HoldingsMEDP
- RevvityRVTY
- ExelixisEXEL
Side by side:GH vs BNTX (Guardant Health, Inc. vs BioNTech)GH vs ALNY (Guardant Health, Inc. vs Alnylam Pharmaceuticals)GH vs ZBH (Guardant Health, Inc. vs Zimmer Biomet Holdings)GH vs THC (Guardant Health, Inc. vs Tenet Healthcare)GH vs VTRS (Guardant Health, Inc. vs Viatris)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Guardant Health, Inc. (GH): questions and answers
What is Guardant Health, Inc.'s market cap?
Guardant Health, Inc. is valued at $19.39B at a share price of $143.34.
Is GH above its 200-week moving average?
Yes. GH is 140.4% above its 200-week average of $59.63. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Guardant Health, Inc. growing?
Over the last five fiscal years Guardant Health, Inc.'s revenue grew 27.9% a year.
Does GH pay a dividend?
Guardant Health, Inc. does not currently pay a regular dividend.
Which famous investors own GH?
In their latest quarterly filings, Eric Bannasch (7.4% of the portfolio), Karthik Sarma (1.7% of the portfolio), Cathie Wood (0.6% of the portfolio), Temasek (0.5% of the portfolio), John Overdeck and David Siegel (founders) (0.4% of the portfolio), Baillie Gifford team (0.3% of the portfolio) hold GH. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Guardant Health, Inc. (GH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GH
Underlying data: Yahoo Finance; company filings with the SEC.